184 related articles for article (PubMed ID: 36564381)
1. Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
Kohli J; Ge C; Fitsiou E; Doepner M; Brandenburg SM; Faller WJ; Ridky TW; Demaria M
Nat Commun; 2022 Dec; 13(1):7923. PubMed ID: 36564381
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
Ruiz-Vega R; Chen CF; Razzak E; Vasudeva P; Krasieva TB; Shiu J; Caldwell MG; Yan H; Lowengrub J; Ganesan AK; Lander AD
Elife; 2020 Oct; 9():. PubMed ID: 33047672
[TBL] [Abstract][Full Text] [Related]
3. On the occurrence of cysteinyldopa and dopa in melanocytes and benign nevi cells.
Falck B; Jacobsson S; Lindvall O; Nietsche UB
Scand J Plast Reconstr Surg; 1976; 10(3):185-8. PubMed ID: 1053447
[TBL] [Abstract][Full Text] [Related]
4. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
5. Melanocytic nevi and melanoma: unraveling a complex relationship.
Damsky WE; Bosenberg M
Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression in human melanocytes and melanocytic tumors.
van den Oord JJ; Vandeghinste N; De Ley M; De Wolf-Peeters C
Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
8. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.
Mukherjee N; Lu Y; Almeida A; Lambert K; Shiau CW; Su JC; Luo Y; Fujita M; Robinson WA; Robinson SE; Norris DA; Shellman YG
Oncotarget; 2017 Jul; 8(29):46801-46817. PubMed ID: 27086916
[TBL] [Abstract][Full Text] [Related]
9. Signalling by senescent melanocytes hyperactivates hair growth.
Wang X; Ramos R; Phan AQ; Yamaga K; Flesher JL; Jiang S; Oh JW; Jin S; Jahid S; Kuan CH; Nguyen TK; Liang HY; Shettigar NU; Hou R; Tran KH; Nguyen A; Vu KN; Phung JL; Ingal JP; Levitt KM; Cao X; Liu Y; Deng Z; Taguchi N; Scarfone VM; Wang G; Paolilli KN; Wang X; Guerrero-Juarez CF; Davis RT; Greenberg EN; Ruiz-Vega R; Vasudeva P; Murad R; Widyastuti LHP; Lee HL; McElwee KJ; Gadeau AP; Lawson DA; Andersen B; Mortazavi A; Yu Z; Nie Q; Kunisada T; Karin M; Tuckermann J; Esko JD; Ganesan AK; Li J; Plikus MV
Nature; 2023 Jun; 618(7966):808-817. PubMed ID: 37344645
[TBL] [Abstract][Full Text] [Related]
10. The relationship between melanocytes and peripheral nerve sheath cells (Part I): melanocytic nevus (excluding so-called "blue nevus") with peripheral nerve sheath differentiation.
Misago N
Am J Dermatopathol; 2000 Jun; 22(3):217-29. PubMed ID: 10871064
[TBL] [Abstract][Full Text] [Related]
11. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.
Bandyopadhyay D; Curry JL; Lin Q; Richards HW; Chen D; Hornsby PJ; Timchenko NA; Medrano EE
Aging Cell; 2007 Aug; 6(4):577-91. PubMed ID: 17578512
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
[TBL] [Abstract][Full Text] [Related]
13. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture.
Plettenberg A; Ballaun C; Pammer J; Mildner M; Strunk D; Weninger W; Tschachler E
Am J Pathol; 1995 Mar; 146(3):651-9. PubMed ID: 7887447
[TBL] [Abstract][Full Text] [Related]
14. Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells.
Rysanek D; Vasicova P; Kolla JN; Sedlak D; Andera L; Bartek J; Hodny Z
Aging (Albany NY); 2022 Aug; 14(16):6381-6414. PubMed ID: 35951353
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
17. Melanocytes express 3G5 surface antigen.
Fiedler E; Nayak RC; Marsch WCh; Helmbold P
Am J Dermatopathol; 2004 Jun; 26(3):200-4. PubMed ID: 15166506
[TBL] [Abstract][Full Text] [Related]
18. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
[TBL] [Abstract][Full Text] [Related]
19. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
Krengel S; Grotelüschen F; Bartsch S; Tronnier M
J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the Hippo tumor suppressor pathway promotes melanoma.
Vittoria MA; Kingston N; Kotynkova K; Xia E; Hong R; Huang L; McDonald S; Tilston-Lunel A; Darp R; Campbell JD; Lang D; Xu X; Ceol CJ; Varelas X; Ganem NJ
Nat Commun; 2022 Jun; 13(1):3732. PubMed ID: 35768444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
